Octreotide
-
Traffic LightAmber (SCG)
-
BNF8.3.4.3
-
Licensed IndicatorsAcromegaly, carcinoid tumours/syndrome. If recommended by the palliative care team. Relief of symptoms from neuroendcrine tumours. Including long-acting formulations.
-
ProvisionalNo
Do you want to add this to your CPD record?
Did you find this page helpful?